期刊文献+

黏附因子CD44的活化状态及其在肿瘤靶向治疗中的研究进展 被引量:2

下载PDF
导出
摘要 CD44(clusterofdifferentiation44)指白细胞分化抗原簇第44号,是一类重要的黏附分子,广泛分布于细胞表面,如淋巴细胞、单核细胞、成纤维细胞、内皮细胞等口]。不同细胞表面CD44与透明质酸(HA)结合活性不同,活化状态存在很大差异。许多正常细胞表面CD44处于相对静止状态,而许多肿瘤细胞表面CD44处于高度活化状态,能与其主要配体HA结合,参与肿瘤的发生、发展及转移等。
作者 侯利丹 高锋
出处 《重庆医学》 CAS CSCD 北大核心 2013年第27期3313-3315,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(81071814 81172027 81272479)
  • 相关文献

参考文献32

  • 1Sneath RJ, Mangham DC. The normal structure and func-tion of CD44 and its role in neoplasia [J]. Mol Pathol.1998,51(4):191-200.
  • 2Afify A,Purnell P,Nguyen L, Role of CD44s and CD44v6on human breast cancer cell adhesion, migration, and inva-sion[J]. Exp Mol Pathol, 2009 ,86(2) :95-100.
  • 3Katoh S,Zheng Z,Oritani K,et al. Glycosylation of CD44negatively regulates its recognition of hyaluronan[J]. JExp Med,1995,182(2) :419-429.
  • 4Levesque MC, Haynes BF. In vitro culture of human pe-ripheral blood monocytes induces hyaluronan binding andup-regulates monocyte variant CD44 isoform expression[J]. J Immunol,1996,156(4) -1557-1565.
  • 5Tzircotis G,Thorne RF, Isacke CM. Chemotaxis towardshyaluronan is dependent on CD44 expression and modula-ted by cell type variation in CD44-hyaluronan binding[J].J Cell Sci,2005,118(21):5119-5128.
  • 6Platt VM,Szoka FC Jr. Anticancer therapeutics: targetingmacromolecules and nanocarriers to hyaluronan or CD44,a hyaluronan receptor [J]. Mol Pharm, 2008 ,5 (4): 474-486.
  • 7Li SD, Howell SB. CD44-targeted microparticles for deliv-ery of cisplatin to peritoneal metastases[J]. Mol Pharm,2009,7(1).280-290.
  • 8Marangoni E,Lecomte N,Durand L,et al. CD44 targetingreduces tumour growth and prevents post-chemotherapyrelapse of human breast cancers xenografts[J]. Br J Canc-er, 2009 ,100(6) : 918-922.
  • 9Choi KY, Yoon HY, Kim JH, et al. Smart nanocarrierbased on PEGylated hyaluronic acid for cancer therapy[J]. ACS Nano,2011,5(11) :8591-8599.
  • 10Hertweck MK, Erdfelder F, Kreuzer KA. CD44 in hema-tological neoplasias[J]. Ann Hematol,2011,90 ( 5 ) : 493-508.

同被引文献40

  • 1王文祥,肖高明,文继舫.CD44、基质金属蛋白酶及其抑制剂与肿瘤浸润和转移[J].中国现代医学杂志,2005,15(5):712-715. 被引量:11
  • 2Hertweck MK,Erdfelder F,Kreuzer KA.CD44 in hematological neoplasias[J].Ann Hematol,2011,90(5):493-508.
  • 3Günthert U,Hofmann M,Rudy W,et al.A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells[J].Cell,1991,65(1):13-24.
  • 4Goi T,Koneri K,Katayama K,et al.Evaluat ion of clinicopathologicalfactors and the correlation between the adhesion molecule CD44 variant 9 expression and pulmonary metastases from colorectalcancers[J].Int Surg,2002,87(2):130-136.
  • 5Barshishat M,Ariel A,Cahalon L,et al.TNF alpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells[J].Clin Exp Metastasis,2002,19(4):327-337.
  • 6Bourguignon LY,Singleton PA,Zhu H,et al.Hyaluronan-mediated CD44 interaction with Rho GEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase sinaling leading to cytokine(macrophage-colony stimulating factor)production and breast tumor progression[J].J Biol Chem,2003,278(32):29420-29434.
  • 7Dustin M.A supercode for inflammation[J].Immunity,2004,20(4):361-362.
  • 8Nilsson SK,Haylock DN,Johnston HM,et al.Hyaluronan is synthesized by primitive hemopoietic cells,participates in their lodgment at the endosteum following transplantation,and is involved in the regulation of their proliferation and differentiation in vitro[J].Blood,2003,101(3):856-862.
  • 9Choi KY,Chung H,Min KH,et al.Self-assembled hyaluronic acid nanoparticles for active tumor targeting[J].Biomaterials,2010,31(1):106-114.
  • 10Coradini D,Zorzet S,Rossin R,et al.Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But[J].Clin Cancer Res,2004,10(14):4822-4830.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部